61 episodes

Ever wish you could get the inside track from the real movers and shakers of the investment world? Well, look no further than the Master Investors podcast. In this exciting new series, Master Investor Magazine Editor-in-Chief James Faulkner gets to pick the brains of fund managers, CEOs, big shot investors and various other luminaries from the investing world, in order to get you - the private investor - up to speed with all the latest themes in what is a very fast-moving and exciting industry.

Master Investors James Faulkner

    • Business
    • 5.0 • 1 Rating

Ever wish you could get the inside track from the real movers and shakers of the investment world? Well, look no further than the Master Investors podcast. In this exciting new series, Master Investor Magazine Editor-in-Chief James Faulkner gets to pick the brains of fund managers, CEOs, big shot investors and various other luminaries from the investing world, in order to get you - the private investor - up to speed with all the latest themes in what is a very fast-moving and exciting industry.

    TPXimpact Holdings PLC: An incredibly cash generative business blending autonomy with responsibility

    TPXimpact Holdings PLC: An incredibly cash generative business blending autonomy with responsibility

    Neal Gandhi founded TPXimpact Holdings (AIM: TPX) with a mission to reduce, and eventually eradicate the bureaucracy that paralyses government programmes at local and central level. The company is a technology-enabled services company focused on digital transformation which in Gandhi’s words: “Empower our teams at the edge to get the job done without bureaucracy.” TPX does that, he says, by pulling together multi-disciplinary teams, to create solutions that work and deliver against the goal for companies. He adds it’s about sharing findings, ensuring great value for taxpayers with the ultimate goal of benefiting society. The client list is impressive and includes DEFRA, the Food Standards Agency and the NHS. TPX counts 50 of the largest 160 local authorities as its clients, and commercial customers include Legal & General and HSBC.  While society benefits, Gandhi wants to make sure shareholders do too. He says the business is incredibly cash generative, and on a run rate basis his and the team’s goal is to deliver £200 million revenue by March 2025.

    • 15 min
    Is the bear market over?

    Is the bear market over?

    In our latest podcast, Mark Slater, founder of Slater Investments, and manager of the Slater Growth and Slater Recovery funds, talks bear markets and stock opportunities in conversation with Jonathan Davis.

    • 31 min
    ANGLE PLC – a small British company changing the world in cancer 

    ANGLE PLC – a small British company changing the world in cancer 

    Andrew Newland founded ANGLE PLC (AIM:AGL) in 1994. Twenty-eight years on and his company has won FDA clearance for ANGLE's liquid biopsy Parsortix initiative which in the U.S. alone has a $100 billion per annum addressable market. "We're solving an enormously challenging and important medical question," says Newland who says the ultimate growth of Parsortix is unbounded.

    • 23 min
    CentralNic Group - fast-growing technology company with 'plenty of blue sky ahead'

    CentralNic Group - fast-growing technology company with 'plenty of blue sky ahead'

    CentralNic Group PLC (AIM:CNIC) global operator and developer of software systems reports on its fantastic start to the year. Revenues were up 86% to $156.6m ($84.4m), its adjusted EBITDA was 83% better at $18.5m ($10.1m), its operating profit was $10.0m ($1.4m), while its net debt was down 18% to $61.3m.The figures reflect the potential of its strong marketplace for Online Presence and Online Marketing services.Ben Crawford, CEO of CentralNic Group PLC, joins us to discuss its successes, the future and what potential acquisitions may lie ahead.

    • 35 min
    ENGAGE XR – Disrupting Global Communication

    ENGAGE XR – Disrupting Global Communication

    David Whelan was stony broke after the 2008 financial crash, but after a €1,000 loan from his sister, and an investment into Oculus headsets he is now the chief executive of dual-listed virtual reality software company ENGAGE XR Holdings PLC (LON:EXR) which is dedicated to the deployment of the metaverse.  The metaverse, according to Whelan, is the evolution of how we communicate online. Currently the internet is like a flat page filled with text and video. Compare that to the metaverse which is about engagement and a breakaway from the internet which can be solitary and divisive. He talks to Master Investor about the company’s pathway to profitability, how everybody should have a stake in the metaverse and the customer profile which tellingly includes Facebook.

    • 27 min
    Investing in the Future of Longevity - the Ketone Chapter

    Investing in the Future of Longevity - the Ketone Chapter

    The field of longevity has long been considered to be theoretical and one for the future, but that future is here now. The science of ketosis promises lucrative opportunities in a wide range of therapeutic areas, and the global keto market is expected to rise to $15 billion by 2027.Juvenescence has brought together the leading experts in the ketone metabolism research field for a panel discussion on the revolution happening with ketones and the direction the research is leading the key players in this space. We cover how ketones can modulate fundamental aspects of human physiology, including glucose metabolism, brain function and heart health.Juvenescence was founded with a mission to transform what aging means to the world. Science around aging is accelerating at an extraordinary pace so we’ve set out to further that science through a coalition of the best scientists, physicians and investors creating cutting-edge therapies and products that will empower people to chart their own path forward. Our company represents a modality-agnostic portfolio of therapies developed by seasoned drug developers augmented by machine learning. We have raised over $200MM to date and are organized around two major divisions: JuvRx (Drug Therapies) and JuvLife (NonRx IP-protected and clinically-studied food ingredients and dietary supplements).Get the experts’ insights on the latest research and development, hear from our founders, Dr. Greg Bailey and Jim Mellon on the opportunity areas in the market.

    • 52 min

Customer Reviews

5.0 out of 5
1 Rating

1 Rating

malfoxley ,

Great show!

James, host of the Master Investors podcast, highlights all aspects of investing and more in this can’t miss podcast! The host and expert guests offer insightful advice and information that is helpful to anyone that listens!

Top Podcasts In Business

Pushkin Industries
Ramsey Network
Andy Frisella #100to0
iHeartPodcasts
NPR
Ed Mylett

You Might Also Like

Future Publishing
Investors Chronicle
AJ Bell
piworld
Financial Times
CONKERS' CORNER